Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE

Peptide receptor radionuclide therapy (PRRT) of metastatic neuroendocrine tumors (NET) can be successfully repeated but may eventually be dose-limited. Since (177)Lu-DOTATATE dose limitation may come from hematological rather than renal function, hematological peripheral blood stem cell backup might...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabet, Amir, Mader, Nicolai, Bittenbring, Jörg Thomas, Khreish, Fadi, Grünwald, Frank, Biersack, Hans Jürgen, Ezziddin, Samer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539404/
https://www.ncbi.nlm.nih.gov/pubmed/34681247
http://dx.doi.org/10.3390/ph14101022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539404/
https://www.ncbi.nlm.nih.gov/pubmed/34681247
http://dx.doi.org/10.3390/ph14101022

Ejemplares similares